At the news
? NEUTRALIMPACT 2/10 8-K filed Oct 30, 2026 at 16:23 ET
Procter & Gamble closed an underwritten public offering of $4.0 billion aggregate principal amount of notes across four tranches (5.125% Notes due 2031, 5.300% Notes due 2033, 5.450% Notes due 2036, and 5.900% Notes due 2056). The filing is a routine debt capital markets transaction with no material impact on equity holders.
- Closed underwritten public offering of $4.0 billion aggregate principal amount of notes on October 30, 2026
- Offering comprised of $750M 5.125% Notes due 2031, $750M 5.300% Notes due 2033, $1.25B 5.450% Notes due 2036, and $1.25B 5.900% Notes due 2056
- Issued under existing Form S-3 shelf registration (No. 333-299472)
- Legal opinions from company counsel and Fried Frank attached as exhibits
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access